Expression and the Physical and Chemical Characterizations Studies of Two Recombinant Human Serum Albumin/interferon-A(2a;2b)fusion Proteins with Long-Acting Bio-Function
FU Yan,HAN Guo,YANG Xiao-nan,FU Yu-song,XING Jing,RU Jun-xin,CHEN Ying,Yun Wen-qi,YU Zai-lin
DOI: https://doi.org/10.3969/cmba.j.issn.1673-713x.2011.02.002
2011-01-01
Abstract:Objective To analyze and compare the physical and chemical characterizations of human serum albumin/interferon alpha-2a fusion protein and human serum albumin/interferon alpha-2b fusion protein drugs.Methods The genetically engineered yeast Pichia pastoris strains used in the expression of rHSA/IFNα2a or rHSA/IFNα2b fusion proteins were constructed separately.The fusion protein was directly secreted by yeast into a simple non-organic culture medium,then purified by three-step highly-efficient chromatography.The physical and chemical characterizations of the highly purified drug-level fusion proteins were investigated in detail.Results Characterization analysis results from the two fusion proteins were obtained including protein purity,which is more than 98%.The first 15 amino acids of the N-terminal sequence of the fusion protein match that of the predicted sequence,with the molecular mass of Maldi-TOF/TOF spectrum being 85788.4D and 85706.1D for rHSA/IFNα2a and rHSA/IFNα2b,respectively.UV-circular dichroism(CD) spectra is not different compared with HSA or interferon-α,and fusion protein's IEF(pI) is around 5.1.The fusion proteins are non-glycoprotein with staining,and UV-wavelength specification shows typical protein spectroscopy.Measurement of free-sulfhydryl(SH) group matchs the predicted value;and mass spectrometric peptide mapping shows 83% or 82% identity to the predicted peptide fragments,respectively.The residues in the bulk preparations are also investigated and meet the standard requirement,including the endotoxin,host protein,exogenous DNA,methanol and glycerol.The immune-identification is positive and the anti-virus bio-assay in vitro is 2.5 × 105 IU/mg,with no difference seen between two fusion proteins.Conclusions The methods used and results obtained from this study may be used as qualification standards in making the clinically available final products of long acting interferon-α protein drugs,Recombinant human serum albumin/interferona2a fusion protein for injection and recombinant human serum albumin/interferona2b fusion protein for injection.